Literature DB >> 2045124

Targeting of T-B interaction using heteroconjugate antibody.

J L Davignon1, M Vallin-Davignon, P L Cohen, R A Eisenberg.   

Abstract

We have deliberately targeted collaboration between T cells and certain B cells by using a heteroconjugate (HETCONJ) antibody. This specific reagent was created by cross-linking the F(ab')2 portions of anti-I-Ab and anti-CD3 monoclonal antibodies. Spleen cells from B6 (I-Ab) but not bm12 (I-Abm12) mice proliferated in vitro in the presence of the HETCONJ. Similarly, T-cell dependent IgM secretion was induced in B cells from B6, yet only weakly in B cells from bm 12 mice. Using B cells from Igh allotype double congenic (B6.C20 Igha/I-Ab and bm12, Ighb/I-Abm12) mice in co-culture experiments, we have used the HETCONJ to study linked versus bystander T-B interaction. B-cell activation, mediated by HETCONJ, was 10 times greater in unseparated than in resting splenic B cells. T-B interaction through T-B contact was more efficient than activation through bystander effects both for unseparated and resting splenic B cells. Large, already activated B cells, in contrast, did not show a preference for linked recognition. Our reagent has mimicked some of the events involved in T-B collaboration and may be useful in studying the molecular basis of cellular interactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045124      PMCID: PMC1384509     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  42 in total

Review 1.  Cognate interactions between helper T cells and B cells.

Authors:  R J Noelle; E C Snow
Journal:  Immunol Today       Date:  1990-10

2.  Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.

Authors:  H Kawamura; J A Berzofsky
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth.

Authors:  K Oliver; R J Noelle; J W Uhr; P H Krammer; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Activation of antigen-specific B cells: role of T cells, cytokines, and antigen in induction of growth and differentiation.

Authors:  R J Noelle; E C Snow; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

Review 5.  Regulation of B-cell growth and differentiation by soluble factors.

Authors:  M Howard; W E Paul
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

6.  Hidden autoantibodies against common serum proteins in murine systemic lupus erythematosus. Detection by in vitro plaque-forming cell assay.

Authors:  P L Cohen; R G Rapoport; R A Eisenberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

7.  Structural differences in cell surface T25 polypeptides from thymocytes and cloned T cells.

Authors:  M Sarmiento; M R Loken; F W Fitch
Journal:  Hybridoma       Date:  1981

8.  Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells.

Authors:  R Ceredig; J W Lowenthal; M Nabholz; H R MacDonald
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

9.  Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.

Authors:  P Perez; R W Hoffman; J A Titus; D M Segal
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

10.  Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.

Authors:  B Karpovsky; J A Titus; D A Stephany; D M Segal
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  2 in total

1.  Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria.

Authors:  H P Beck; I Felger; B Genton; N Alexander; F al-Yaman; R F Anders; M Alpers
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

2.  Promotion of natural killer cell growth in vitro by bispecific (anti-CD3 x anti-CD16) antibodies.

Authors:  A M Malygin; K Somersalo; T Timonen
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.